CLOV - Latest News

Clover Health Investments, Corp. (CLOV), operates in Healthcare / Medical - Healthcare Plans, trades on NASDAQ.

Market capitalization stands near $2.80B. Beta to the broader market is 2.48.

The article list below shows the most recent CLOV headlines from major financial news vendors. For options traders, the most actionable items are earnings releases, analyst rating changes, M&A activity, and regulatory filings - each can drive a meaningful repricing of implied volatility and shift dealer hedging flow. Pair the news context with the implied-volatility skew and gamma exposure views to see whether the options market has already priced in the headline.

Recent CLOV Headlines

A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.

fool.com - Jun 27, 2026

Director Carladenise Edwards sold 67,160 shares for a transaction value of approximately ~$230,000 on May 18, 2026, at a weighted average price of aro

Clover Health Stock Extends Gains After Court Forces CMS to Upgrade Medicare Star Rating

benzinga.com - Jun 11, 2026

Clover Health Investments Corp. (NASDAQ:CLOV) shares are extending yesterday's 18.

A Clover Health Insider Sold Over 220,000 Company Shares. What Does That Mean for Investors?

fool.com - Jun 5, 2026

This healthcare technology company focused on Medicare Advantage plans saw a notable insider sale following a year of strong stock gains.

Clover Health Investments, Corp. (CLOV) Q1 2026 Earnings Call Transcript

seekingalpha.com - May 7, 2026

Clover Health Investments, Corp.

Clover Health Q1 Earnings Meet Estimates, Sales Beat, Membership Rises

zacks.com - May 7, 2026

CLOV posts 62% revenue growth in Q1 as Medicare Advantage membership surges and AI-driven care initiatives boost profitability.

How News Affects CLOV Options Pricing

Headlines and scheduled events drive implied volatility in two distinct ways. Pre-event, IV typically inflates as uncertainty about the outcome rises; this is the implied-volatility expansion that creates the long-vol setup. Post-event, IV typically contracts sharply as uncertainty resolves; this is IV crush, which makes premium-selling structures profitable when they survive the underlying move. The size of the crush depends on how stretched pre-event IV is relative to the realized move. Track CLOV's implied vs realized volatility over the news cycle to size pre-event vs post-event positioning. For ticker-level dealer positioning context, the gamma exposure view shows whether dealers are positioned to amplify or dampen post-news moves.

Frequently asked CLOV news questions

What is the latest CLOV news headline?

The most recent CLOV headline (Jun 27, 2026) is "A Clover Health Director Sold Over 67,000 Company Shares. Here's a Closer Look at the Transaction.". The five most recent stories with summaries and publication times are listed above, sourced from major financial news vendors.

How fresh is the CLOV news on this page?

News rows refresh roughly every 30 minutes during the trading day. The five most recent headlines are listed in publication-time order. Press releases from the company itself typically appear within minutes of the wire release; third-party reporting may lag by 30-60 minutes depending on the source.

What CLOV news moves options pricing?

Three categories move single-name IV most aggressively: scheduled earnings releases (priced into pre-event IV, crushed post-event), unscheduled M&A or strategic announcements (rapid IV expansion, slower decay), and regulatory or legal events (drug-trial readouts, antitrust filings, FDA approvals). Routine news flow (analyst commentary, sector rotation) typically does not move IV meaningfully unless it triggers a cluster of rating changes.

How can I track unusual CLOV options activity related to news?

Unusual options activity often precedes news by hours to days; the canonical signals are volume substantially above the trailing average concentrated in a small number of strikes, atypical put/call skew, and aggressive execution (at-the-ask sweeps or block prints). Cross-reference the per-ticker gamma-exposure and volume-history pages with the news flow above to triangulate informed vs uninformed flow.